Richard van Wijk

Richard van Wijk

Auto-generated profile, based on publicly available information

Richard van Wijk

Red Blood Cell Research Group, Central Diagnostic Laboratory‐Research, University Medical Centre Utrecht Utrecht University Utrecht The Netherlands

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
RHRick Huisjes
Rick Huisjes
Anna BogdanovaAnna Bogdanova
Anna Bogdanova
WSWouter van Solinge
Wouter van Solinge
RSRaymond Schiffelers
Raymond Schiffelers
Lars KaestnerLars Kaestner
Lars Kaestner
RWRichard van Wijk
Richard van Wijk
Deformability is an essential feature of blood cells (RBCs) that enables them to travel through even the smallest capillaries of the human body. Deformability is a function of (i) structural elements of cytoskeletal proteins, (ii) processes controlling intracellular ion and water handling and (iii) membrane surface-to-volume ratio. All these factors may be altered in various forms of hereditary hemolytic anemia, such as sickle cell disease, thalassemia, hereditary spherocytosis and hereditary xerocytosis. Although mutations are known as the primary causes of these congenital anemias, little is known about the resulting secondary processes that affect RBC deformability (such as secondary changes in RBC hydration, membrane protein phosphorylation, and RBC vesiculation). These secondary processes could, however, play an important role in the premature removal of the aberrant RBCs by the spleen. Altered RBC deformability could contribute to disease pathophysiology in various disorders of the RBC. Here we review the current knowledge on RBC deformability in different forms of hereditary hemolytic anemia and describe secondary mechanisms involved in RBC deformability.

31 July 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
VPVirginia Pretini
Virginia Pretini
MKMischa H. Koenen
Mischa H. Koenen
Lars KaestnerLars Kaestner
Lars Kaestner
MFMarcel H. A. M. Fens
Marcel H. A. M. Fens
RSRaymond M. Schiffelers
Raymond M. Schiffelers
RWRichard Van Wijk
Richard Van Wijk
Human red blood cells (RBC) are highly differentiated cells that have lost all organelles and most intracellular machineries during their maturation process. RBC are fundamental for the nearly all basic physiologic dynamics and they are key cells in the body's respiratory system by being responsible for the oxygen transport to all cells and tissues, and delivery of carbon dioxide to the lungs. With their flexible structure RBC are capable to deform in order to travel through all blood vessels including very small capillaries. Throughout their in average 120 days lifespan, human RBC travel in the bloodstream and come in contact with a broad range of different cell types. In fact, RBC are able to interact and communicate with endothelial cells (ECs), platelets, macrophages, and bacteria. Additionally, they are involved in the maintenance of thrombosis and hemostasis and play an important role in the immune response against pathogens. To clarify the mechanisms of interaction of RBC and these other cells both in health and disease as well as to highlight the role of important key players, we focused our interest on RBC membrane components such as ion channels, proteins, and phospholipids.

1 January 2013 in Frontiers in Physiology
Verified
Journal Article
Open access
AAAmr Alaarg
Amr Alaarg
RSRaymond Schiffelers
Raymond Schiffelers
WSWouter van Solinge
Wouter van Solinge
RWRichard van Wijk
Richard van Wijk
Hereditary hemolytic anemia encompasses a heterogeneous group of anemias characterised by decreased red blood cell survival because of inherited membrane, enzyme, or hemoglobin disorders. Affected red blood cells are more fragile, less deformable, and more susceptible to shear stress and oxidative damage, and show increased vesiculation. Red blood cells, as essentially all cells, constitutively release phospholipid extracellular vesicles in vivo and in vitro in a process known as vesiculation. These extracellular vesicles comprise a heterogeneous group of vesicles of different sizes and intracellular origins. They are described in literature as exosomes if they originate from multi-vesicular bodies, or as microvesicles when formed by a one-step budding process directly from the plasma membrane. Extracellular vesicles contain a multitude of bioactive molecules that are implicated in intercellular communication and in different biological and pathophysiological processes. Mature red blood cells release in principle only microvesicles. In hereditary hemolytic anemias, the underlying molecular defect affects and determines red blood cell vesiculation, resulting in shedding microvesicles of different compositions and concentrations. Despite extensive research into red blood cell biochemistry and physiology, little is known about red cell deformability and vesiculation in hereditary hemolytic anemias, and the associated pathophysiological role is incompletely asessed. In this review, we discuss recent progress in understanding extracellular vesicles biology, with focus on red blood cell vesiculation. Also, we review recent scientific findings on the molecular defects of hereditary hemolytic anemias, and their correlation with red blood cell deformability and vesiculation. Integrating bio-analytical findings on abnormalities of red blood cells and their microvesicles will be critical for a better understanding of the pathophysiology of hereditary hemolytic anemias.

18 April 2014 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
PKP. Koralkova
P. Koralkova
WSWouter van Solinge
Wouter van Solinge
RWR. van Wijk
R. van Wijk

23 January 2020 in Haematologica
Verified
Journal Article
Open access
PDF file
MRMinke A.E. Rab
Minke A.E. Rab
BOBrigitte A. Van Oirschot
Brigitte A. Van Oirschot
PKPenelope A. Kosinski
Penelope A. Kosinski
JHJeffrey Hixon
Jeffrey Hixon
KJKendall Johnson
Kendall Johnson
RWRichard Van Wijk
Richard Van Wijk
Pyruvate kinase (PK) deficiency is a rare hereditary disorder affecting red cell (RBC) glycolysis, causing changes in metabolism including a deficiency in ATP. This affects red cell homeostasis, promoting premature removal of RBCs from the circulation. In this study we characterized and evaluated the effect of AG-348, an allosteric activator of PK that is currently in clinical trials for treatment of PK deficiency, on RBCs and erythroid precursors from PK-deficient patients. In 15 patients ex vivo treatment with AG-348 resulted in increased enzymatic activity in all patient cells after 24 hours (mean increase 1.8-fold, range 1.2-3.4). ATP levels increased (mean increase 1.5-fold, range 1.0-2.2) similar to control cells (mean increase 1.6-fold, range, 1.4-1.8). Generally, PK thermostability was strongly reduced in PK-deficient RBCs. Ex vivo treatment with AG-348 increased residual activity 1.4 to >10-fold than residual activity of vehicle-treated samples. Protein analyses suggests that a sufficient level of PK protein is required for cells to respond to AG-348 treatment ex-vivo, as treatment effects were minimal in patient cells with very low or undetectable levels of PK-R. In half of the patients, ex vivo treatment with AG-348 was associated with an increase in RBC deformability. These data support the hypothesis that drug intervention with AG-348 effectively upregulates PK enzymatic activity and increases stability in PK-deficient RBCs over a broad range of PKLR genotypes. The concomitant increase in ATP levels suggests that glycolytic pathway activity may be restored. AG-348 treatment may represent an attractive way to correct the underlying pathologies of PK deficiency. (AG-348 is currently in clinical trials for the treatment of PK deficiency. ClinicalTrials.gov: NCT02476916, NCT03853798, NCT03548220, NCT03559699).

14 December 2017 in Haematologica
Verified
Journal Article
Open access
PDF file
SSStephanie van Straaten
Stephanie van Straaten
MBMarc Bierings
Marc Bierings
PBPaola Bianchi
Paola Bianchi
KAKensuke Akiyoshi
Kensuke Akiyoshi
HKHitoshi Kanno
Hitoshi Kanno
RWRichard van Wijk
Richard van Wijk